 ft 18 92 intern compani news astra ulcer therapi threaten glaxo sale  astra swedish pharmaceut group believ develop therapi peptic ulcer undermin sale zantac world sell drug generat annual revenu dollar 3bn glaxo uk treatment erad bacterium helicobact pylori hp specialist signific recur peptic ulcer elimin hp astra believ reduc long term prevent therapi glaxo estim 40 50 cent zantac prescript long term mainten therapi astra test combin losec ulcer drug antibiot patient infect hp studi reveal week annual convent american gastroenterolog associ show drug erad hp 80 cent duoden ulcer patient patient remain ulcer free 12 month treatment effect erad hp mr robin gilbert pharmaceut analyst jame capel previous treatment elimin bug requir take 18 pill day separ occas hospit environ import treatment pill day prescrib general practition need combin fulfil earli promis revolutionis market mr gilbert mainten market virtual disappear astra claim combin work losec reduc acid content stomach allow antibiot work effect antibiot withstand acid prove effect patient built resist 